Rayno Life Science Portfolio Movers: ALXN, AMRI, CBST

Rayno Life Science picks had earnings news and overall the Portfolio was up 1%.

can you order Lyrica online Albany Molecular (AMRI $3.49) stock was up 5.44% on low volume but showing steady recovery from recent lows in the $3 range. AMRI is a value stock trading at a market cap of $105M with forecasted revenues in the $222M range. Albany molecualr is a CRO focused in pharmaceuticals but has its own R&D group.

http://lstyle.sk/o-nas/certifikaty/011v/ Alexion (ALXN $66.76 ) beat EPS by $0.09 and beat on revenues and raised EPS.because of orphan drug product Soliris with $204M in sales for quarter. The stock was up 1%.

http://qualityfirstcontractor.com/wp-json/oembed/1.0//"http:////qualityfirstcontractor.com//2015//10//pella-window-bow///" Cubist (CBST $39.92) stock soared 9.6% on raised revenue outlook with net revenues up 24% for the quarter to $201.7M. Cubist EPS declined to $0.33 from $0.50. Cubist’s partner Optimer(OPTR) was also up 9.6%.

Keep an eye on Illumina (ILMN $26.90) as the sell-off is abating at the $26 level.

No comments yet.

Leave a Reply